Vanguard Group Inc Pacira Bio Sciences, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,241,804 shares of PCRX stock, worth $138 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,241,804

Previous 5,263,919 0.42%

Holding current value

$138 Million

Previous $99.2 Million 31.35%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$18.33 - $27.25 $405,367 - $602,633	-22,115 Reduced 0.42%	5,241,804 $130 Million
Q4 2024 Feb 11, 2025	SELL	$15.3 - $20.33 $531,889 - $706,752	-34,764 Reduced 0.66%	5,263,919 $99.2 Million
Q3 2024 Nov 13, 2024	BUY	$11.7 - $28.46 $2.5 Million - $6.09 Million	213,852 Added 4.21%	5,298,683 $79.8 Million
Q2 2024 Aug 13, 2024	SELL	$25.5 - $31.51 $728,101 - $899,705	-28,553 Reduced 0.56%	5,084,831 $145 Million
Q1 2024 May 10, 2024	BUY	$27.7 - $35.48 $414,392 - $530,780	14,960 Added 0.29%	5,113,384 $149 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $3.73 Million - $4.86 Million	141,719 Added 2.86%	5,098,424 $172 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $134,777 - $176,115	4,393 Added 0.09%	4,956,705 $152 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $935,724 - $1.23 Million	-25,906 Reduced 0.52%	4,952,312 $198 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $1.88 Million - $2.3 Million	53,023 Added 1.08%	4,978,218 $203 Million
Q4 2022 Feb 10, 2023	BUY	$38.19 - $57.45 $2.17 Million - $3.26 Million	56,750 Added 1.17%	4,925,195 $190 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $2.83 Million - $3.25 Million	55,188 Added 1.15%	4,868,445 $259 Million
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $6.44 Million - $10.2 Million	125,138 Added 2.67%	4,813,257 $281 Million
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $1.33 Million - $1.7 Million	22,164 Added 0.48%	4,688,119 $358 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $4.9 Million - $6.35 Million	-102,108 Reduced 2.14%	4,665,955 $281 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $2.36 Million - $2.64 Million	43,134 Added 0.91%	4,768,063 $267 Million
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $280 Million - $331 Million	4,724,929 New	4,724,929 $287 Million

Others Institutions Holding PCRX

# of Institutions

254

Shares Held

51.1M

Call Options Held

157K

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.2B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Pacira Bio Sciences, Inc. Transaction History